AGG01

WikiDoc Resources for AGG01
Articles
Most recent articles on AGG01 Most cited articles on AGG01 Review articles on AGG01 Articles on AGG01 in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on AGG01 Images of AGG01 Photos of AGG01 Podcasts & MP3s on AGG01 Videos on AGG01
Evidence Based Medicine
Cochrane Collaboration on AGG01 Bandolier on AGG01 TRIP on AGG01
Clinical Trials
Ongoing Trials on AGG01 at Clinical Trials.gov Trial results on AGG01 Clinical Trials on AGG01 at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on AGG01 NICE Guidance on AGG01 NHS PRODIGY Guidance FDA on AGG01 CDC on AGG01
Books
Books on AGG01
News
AGG01 in the news Be alerted to news on AGG01 News trends on AGG01
Commentary
Blogs on AGG01
Definitions
Definitions of AGG01
Patient Resources / Community
Patient resources on AGG01 Discussion groups on AGG01 Patient Handouts on AGG01 Directions to Hospitals Treating AGG01 Risk calculators and risk factors for AGG01
Healthcare Provider Resources
Symptoms of AGG01 Causes & Risk Factors for AGG01 Diagnostic studies for AGG01 Treatment of AGG01
Continuing Medical Education (CME)
CME Programs on AGG01
International
AGG01 en Espanol AGG01 en Francais
Business
AGG01 in the Marketplace Patents on AGG01
Experimental / Informatics
List of terms related to AGG01

AGG01 is the tentative name of a new Penicillin-class antibiotic, recently discovered in the breast milk of the Tammar Wallaby, reportedly one hundred times more powerful than penicillin.

This compound was found to be effective against MRSA, E. coli, Streptococci, Salmonella, Bacillus subtilis, Pseudomonas spp., Proteus vulgaris, and Staphylococcus aureus.

AGG01 has not yet been classified as a Beta-lactam antibiotic.

AGG01 is a cationic peptide, which is a polycationic protein which is rich in positive residues of the amino acidss arginine and lysine, and which folds into an amphipathic structure (one which has both hydrophobic and hydrophilic areas). These features mean that it can interact with the anionic lipids in the bacterial membrane, such as phosphatidylglycerol. It inserts itself into the membrane, by competing with cross-linking proteins between each membrane layer, and then sets up trans-membrane protein channels which induce ion transport out of the cell. This causes huge leakage via osmosis through these 'pores’ and the general consensus is that the loss of these essential molecules is the mechanism by which bacteria are killed. The bacterial membrane has a different structure from the mammalian plasma membrane, so the protein can only kill pathogenic cells and not human ones.

References

Template:WH Template:WikiDoc Sources